Methylone, sometimes abbreviated as MDMC, is an illicit drug that has been sold under the label of bath salts, Molly (suggesting that it is a potential substitute for ecstasy), MDMCAT, and numerous other street names.
There is an injectable corticosteroid that is used medicinally for the treatment of arthritis and allergic reactions that is sold under the brand name of Methylone, but this is not the same drug.
MDMC is a potentially dangerous drug of abuse.
MDMC is a synthetic or man-made drug that is similar to natural occurring amphetamine substances like the cathinones that occur in the khat plant found in parts of Asia (Catha edulis). This plant has been used by people who live in the area where it naturally occurs as a stimulant for many years.
The substance was first artificially synthesized in the 1990s. It was designed to act as antidepressant medication, but it did not fulfill its potential in this capacity.
Methylone is classified by the U.S. Drug Enforcement Administration as a Schedule I controlled substance. This means that the drug cannot be legally obtained under any circumstances by private individuals and cannot be prescribed for any medical reasons.
Anyone distributing or using the substance is subject to prosecution unless they have special permissions from the United States government to obtain it and use it (most often, for research purposes).
The chemical structure of methylone is similar to amphetamines like methamphetamine and ecstasy (Molly); however, the drug is not the same as ecstasy.
The most common way to abuse methylone is to snort the powder. However, people can take it in any number of ways, including swallowing it, mixing it with water or another substance and injecting it, smoking it with other drugs like cannabis products, or even using it rectally.
Methylone use results in a release of the neurotransmitters serotonin, dopamine, and norepinephrine.
The drug appears to increase the amounts of these neurotransmitters in the brain by both facilitating their release and blocking their reuptake back into the neurons once they are released and have performed their functions.
Descriptions from individuals who abuse the drug indicate that its effects are similar to methamphetamine (crystal meth) and MDMA (ecstasy or Molly). The effects that most abusers report include:
The effects of the drug depend on the method in which it is abused. Smoking it will bring on effects the quickest, followed by injecting it, then snorting it, and then using the drug orally.
If the drug is ingested orally, it still has a relatively rapid absorption rate. Feelings of euphoria occur within 90 minutes and last for up to four hours.
Feelings of increased energy and euphoria will peak within a few hours. The peak is followed by a long-lasting crash or comedown that can last up to eight hours or more.
There are many potential adverse effects of using methylone. This long list of negative effects resulted in it not being used medicinally as an antidepressant or for other medicinal reasons.
The following are short-term, less serious side effects of abuse:
In addition to the immediate and less threatening adverse reactions listed above, which are common manifestations of short-term abuse, there are long-term effects of using methylone that can be very serious.
Chronic use of the drug can lead to significant adverse reactions that may not fully resolve even with continued abstinence.
The most common of these effects include:
Any substance that can produce psychosis or seizures is a potentially dangerous substance.
The potential for an overdose with methylone is significant. There are documented fatalities associated with overdose of the drug.
Deaths associated with an overdose of MDMC often occur as a result of cardiac arrest, seizures, or using methylone in conjunction with other dangerous substances like opioids, stimulants, and other drugs.
The primary users of methylone are younger individuals who cannot legally obtain certain drugs like alcohol, cannabis products where they are legal, or other drugs. Substances containing methylone are often offered over the internet.
According to the Monitoring the Future study, the abuse of drugs labeled as “bath salts” has remained relatively low among individuals in middle school and high school since 2015 (less than 1 percent) following a peak in 2009 to 2011.
There are some indications that there might be a recent minor upsurge in the use of these drugs, but as of yet, this trend is not confirmed.
The research on the potential of the drug to produce physical dependence is mixed. However, it does appear that individuals who use the drug for lengthy periods of time develop tolerance to its effects and need more of the drug to get the effects that they got with lower doses.
If withdrawal symptoms do occur with extended abuse of the drug, they are most likely similar to the withdrawal syndrome associated with discontinuing other stimulants.
The major symptoms of withdrawal associated with discontinuing stimulants include:
There are no specific medications that are used in the treatment of withdrawal from MDMC.
Physicians addressing withdrawal from methylone may administer medications that address the specific symptoms the person is displaying. For example, those experiencing significant cravings could be given drugs like ReVia (naltrexone) whereas those dealing with lethargy or sleepiness might be given a very mild stimulant like Provigil (modafinil).
The drug is a Schedule I controlled substance which means that anyone suspected of using it should be considered abusing it.
In addition to addressing any potential signs of withdrawal, the person needs to become involved in a comprehensive substance use disorder treatment program.
The program would need to:
(February 2019). Methylone. National Center for Biotechnology Information. PubChem Compound Database. Retrieved February 2019 from https://pubchem.ncbi.nlm.nih.gov/compound/methylone
(September 2015). The psychostimulant drug khat (Catha edulis): A mini-review. Phytochemistry Letters. Retrieved February 2019 from https://www.sciencedirect.com/science/article/pii/S1874390015001135
(N.D.). Drug Scheduling. U.S. Drug Enforcement Administration. Retrieved January 2019 from https://www.dea.gov/drug-scheduling
(April 2012). The Designer Methcathinone Analogs, Mephedrone and Methylone, are substrates for Monoamine Transporters in Brain tissue. Neuropsychopharmacology. Retrieved February 2019 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306880/
(September 2012). Synthetic cathinones (‘bath salts’): legal and health care challenges. Pharmacy and Therapeutics. Retrieved February 2019 from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474442/
(June 2015). Methylone-induced Hyperthermia and Lethal Toxicity: Role of the Dopamine and Serotonin Transporters. Behavioural Pharmacology. Retrieved February 2019 from https://www.ncbi.nlm.nih.gov/pubmed/25794333
(January 2019). Monitoring the Future Study: Trends in Prevalence of Various Drugs. National Institute on Drug Abuse. Retrieved February 2019 from https://www.drugabuse.gov/trends-statistics/monitoring-future/monitoring-future-study-trends-in-prevalence-various-drugs